IDR 1060.0
(-2.3%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 71.81 Billion IDR | -6.58% |
2022 | 76.87 Billion IDR | -15.53% |
2021 | 91.01 Billion IDR | 76.14% |
2020 | 51.66 Billion IDR | 57.07% |
2019 | 32.89 Billion IDR | -0.11% |
2018 | 32.93 Billion IDR | 46.07% |
2017 | 22.54 Billion IDR | 35.44% |
2016 | 16.64 Billion IDR | -8.2% |
2015 | 18.13 Billion IDR | 15.3% |
2014 | 15.72 Billion IDR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 20.63 Billion IDR | 0.89% |
2024 Q2 | 20.71 Billion IDR | -14.17% |
2024 Q1 | 24.13 Billion IDR | 11.91% |
2023 Q3 | 16.05 Billion IDR | -2.91% |
2023 FY | 71.81 Billion IDR | -6.58% |
2023 Q1 | 17.65 Billion IDR | 227.75% |
2023 Q2 | 16.53 Billion IDR | -6.35% |
2023 Q4 | 21.56 Billion IDR | 34.34% |
2022 Q2 | 38.48 Billion IDR | 15.93% |
2022 Q3 | 19.01 Billion IDR | -50.61% |
2022 Q4 | -13.82 Billion IDR | -172.71% |
2022 FY | 76.87 Billion IDR | -15.53% |
2022 Q1 | 33.19 Billion IDR | 13.92% |
2021 Q3 | 28.69 Billion IDR | 60.03% |
2021 FY | 91.01 Billion IDR | 76.14% |
2021 Q4 | 29.14 Billion IDR | 1.54% |
2021 Q1 | 15.23 Billion IDR | -35.71% |
2021 Q2 | 17.93 Billion IDR | 17.72% |
2020 Q1 | 7.92 Billion IDR | 9.7% |
2020 Q2 | 8.11 Billion IDR | 2.31% |
2020 FY | 51.66 Billion IDR | 57.07% |
2020 Q4 | 23.69 Billion IDR | 98.65% |
2020 Q3 | 11.92 Billion IDR | 47.04% |
2019 Q4 | 7.22 Billion IDR | -30.89% |
2019 FY | 32.89 Billion IDR | -0.11% |
2019 Q3 | 10.45 Billion IDR | 20.32% |
2019 Q2 | 8.69 Billion IDR | 33.4% |
2019 Q1 | 6.51 Billion IDR | -15.82% |
2018 Q3 | 10.01 Billion IDR | 37.06% |
2018 FY | 32.93 Billion IDR | 46.07% |
2018 Q4 | 7.74 Billion IDR | -22.69% |
2018 Q1 | 7.87 Billion IDR | 34.22% |
2018 Q2 | 7.3 Billion IDR | -7.27% |
2017 FY | 22.54 Billion IDR | 35.44% |
2017 Q1 | 4.78 Billion IDR | -19.71% |
2017 Q2 | 5.17 Billion IDR | 8.22% |
2017 Q3 | 6.71 Billion IDR | 29.76% |
2017 Q4 | 5.86 Billion IDR | -12.63% |
2016 Q3 | 2.46 Billion IDR | -21.73% |
2016 FY | 16.64 Billion IDR | -8.2% |
2016 Q2 | 3.14 Billion IDR | 0.0% |
2016 Q1 | 3.14 Billion IDR | 0.0% |
2016 Q4 | 5.95 Billion IDR | 141.85% |
2015 FY | 18.13 Billion IDR | 15.3% |
2014 FY | 15.72 Billion IDR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
PT Hetzer Medical Indonesia Tbk | 10.89 Billion IDR | -559.337% |
PT Jayamas Medica Industri Tbk | 249.36 Billion IDR | 71.2% |
Maja Agung Latexindo Tbk. | 13.96 Billion IDR | -414.32% |